Reducing the Usage of Oral Corticosteroids in the Management of Asthma: A Part of the BREATHE Initiative
Track 2: Immunologist

Questions marked with a * are required

24%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

What are potential concerns when using oral corticosteroids?

Risk of diabetes

Risk of osteoporosis

Risk of worsening exacerbations

A and B

All of the above

The biologic data in patients with moderate-to-severe asthma demonstrates:

That co-morbidities, like nasal polyps, can be effectively treated along with the patient’s asthma

That some of the biologic agents can reduce and potentially eliminate the need for oral corticosteroids

That a patient’s biomarkers can predict the efficacy of specific biologics

A and B

All of the above

Morgan is a 48-year-old woman (5’ 4”, 160 lbs). Her asthma was diagnosed by her internist 2 years ago. Her last exacerbation was 2 months ago. She has been referred to you with the following past medical history.

Frequent productive cough
Exacerbations (wheezing, coughing, SOB) every 3-5 months with the last episode requiring oral corticosteroids

Her past medical history is significant for:

Chronic sinusitis without nasal polyps

Prior asthma medications were:

Fluticasone propionate/ salmeterol 500 μg/50 μg twice daily

Current asthma medications are (started 6 months ago):

High-dose budesonide/formoterol fumarate dihydrate inhaler
Tiotropium inhaler
Prednisone 15 mg PO daily (started 2 months ago)

What risks are you concerned with secondary to her oral corticosteroids?

Osteoporosis

Weight gain

Dose is low enough, so no concerns

A and B

Powered by QuestionPro

Loading...